載入...
免疫检查点抑制剂相关肾脏不良反应的临床诊治建议
Immune checkpoint inhibitors (ICIs) have been used more and more Increasingly in clinical oncology treatment, which has significantly improved the prognosis of cancer patients. Over-activation of T cells and related signaling pathways may cause immune-related adverse effects. Renal immune side-effec...
Na minha lista:
| 發表在: | Zhongguo Fei Ai Za Zhi |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
中国肺癌杂志编辑部
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817426/ https://ncbi.nlm.nih.gov/pubmed/31650947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.07 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|